Infinitus Bioinformatics is strategically partnered with e-Therapeutics plc, http://www.etherapeutics.co.uk/en/partnerships
a systems biology drug discovery and development company based in Newcastle, UK. e-Therapeutics focuses on two distinct but related activities: proprietary drug discovery and development, and consultancy, contract research services and partnerships. Both activities use the Company’s proprietary network analytical systems and aim to generate or de-risk drug candidates, thereby identifying the best probability of a strong efficacy profile in the target disease with minimum tolerance and side effect issues. This partnership enables us to complement the novel and successful approach of e-Therapeutics and together provide an unparalleled service to third party clients.

Our team of scientists has been associated with e-Therapeutics for the last four years. We have partnered with e-Therapeutics in their research areas of Melanoma, Prostate cancer, Alzheimer’s, anti-infectives, Fibromyalgia, among others. Our scientists have been instrumental in establishing a comprehensive knowledge base for the company. e-Therapeutics currently has a pipeline of twelve candidates in different stages of discovery and clinical development in ten indications.